Latest news

  • Innovative TB treatment support project kicks off in the Philippines

    Wednesday 25 September

    ASCENT aims to assist patients succeed in treatment using digital adherence technology. On World Lung Day, the innovative TB treatment support project ASCENT kicks off in the Philippines, making the […]

    Read more
  • Antacid helps tuberculosis bacteria to survive

    Sunday 1 September

    In 2017, some 10 million people suffered from tuberculosis and 1.6 million died of the disease. One reason why infection with Mycobacterium tuberculosis is so difficult to treat is that […]

    Read more
  • FDA approval of BPaL regimen an important breakthrough in TB control

    Wednesday 14 August

    The US Food & Drug Administration (FDA) today approved pretomanid for the treatment of highly drug-resistant forms of tuberculosis (TB) in a combination regimen known as BPaL. This regimen was […]

    Read more
  • ASCENT: Empowering patients through digital technology

    Tuesday 23 July

    GENEVA/THE HAGUE, The next three and a half years, KNCV Tuberculosis Foundation will lead the innovative ASCENT project, which stands for Adherence Support Coalition to End TB. This brand new […]

    Read more
  • Call to Action for awareness on AMR

    Thursday 20 June

    KNCV Tuberculosis Foundation is one of the civil society organizations that signs the Call to Action for awareness on antimicrobial resistance (AMR) in the Netherlands. Kitty van Weezenbeek, director of […]

    Read more
  • Wolfheze Workshops 2019: inspiring knowledge exchange & concrete steps forward

    Tuesday 28 May

    KNCV Tuberculosis Foundations can look back at an inspiring edition of the Wolfheze Workshops 2019 (15-17 May). In Scheveningen 160 TB experts from over 40 countries from Western Europe, Eastern […]

    Read more
  • Unique gathering of TB and HIV experts in Scheveningen

    Wednesday 15 May

    Biennial Wolfheze Workshops focuses on alarming tandem of infectious diseases THE HAGUE, 15 May 2019 International experts in the field of tuberculosis (TB) and HIV control meet today in Scheveningen […]

    Read more
  • Dutch civil society calls upon increase of Dutch commitment to the Global Fund

    Friday 12 April

    The Hague – This week, KNCV Tuberculosis Foundation, in cooperation with Aidsfonds and nine other Dutch civil society organisations* called upon the Dutch Minister for Trade and Development Cooperation, Sigrid […]

    Read more
  • IT’S TIME … for new TB drugs and treatment regimens for all

    Sunday 24 March

    THE HAGUE – Today, on World TB Day, the international TB community raises awareness about the deadliest infectious disease in the world. In that context, KNCV Tuberculosis Foundation (KNCV) presents […]

    Read more
  • TB remains major public health challenge in European region

    Tuesday 19 March

    The latest WHO/ECDC report Tuberculosis surveillance and monitoring in Europe 2019 (2017 data) shows that despite an overall decline in numbers of people suffering from TB, the disease remains a […]

    Read more
  • Promising results from new drugs and shorter regimen in Kyrgyzstan

    Thursday 14 March

    The Government of the Kyrgyz Republic and USAID announced major advancements in the fight against the ongoing tuberculosis epidemic in the country. New life-saving treatments are showing promising results only […]

    Read more
  • Short Regimen for Preventing TB Found Safe When Co-administered with New First-line HIV Drug

    Friday 8 March

    New study paves the way for scale-up of TB prevention among people living with HIV, who are dying from TB in large numbers SEATTLE (6 March 2019)—In an important moment […]

    Read more